Premium
PK/PD study of BIBR 363 CL 2 , a long‐lasting angiotensin II (A‐II) antagonist. Prediction of optimal doses for multiple dosing from single dose results
Author(s) -
Hecht A.,
Heinzel G.,
Stangier J.,
Duong D.N.,
Su C.A.P.F.
Publication year - 1996
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/sj.clpt.1996.151
Subject(s) - dosing , antagonist , pharmacology , medicine , angiotensin ii , blood pressure , receptor
Clinical Pharmacology & Therapeutics (1996) 59 , 163–163; doi: 10.1038/sj.clpt.1996.151